OXBDF - Oxford Biomedica plc (OXBDF) CEO John Dawson on Q2 2020 Results - Earnings Call Transcript
Oxford Biomedica plc (OXBDF)
Q1 2020 Earnings Conference Call
Sep 17, 2020 8:00 AM ET
Company Participants
Catherine Isted - Head, Corporate Development and Investor Relations
John Dawson - Chief Executive Officer
Stuart Paynter - Chief Financial Officer
Conference Call Participants
Amy Walker - Peel Hunt
Charles Weston - RBC
Joe Pantginis - H.C. Wainwright
Julie Simmonds - Panmure Gordon
Alistair Campbell - Liberum
Stefan Hamill - Numis Securities
Presentation
Catherine Isted
Good afternoon, ladies and gentlemen, and welcome to Oxford Biomedica's Interim Results Conference Call. We are delighted today to talk through what hopefully